Teva Pharmaceutical Industries Limited Share Price London S.E.
Equities
0LER
US8816242098
Pharmaceuticals
Market Closed -
Other stock markets
|
After market 11:50:28 pm | |||
13.82 USD | -1.25% | 14.02 | +1.45% |
Sales 2024 * | 15.86B 1,324B | Sales 2025 * | 16.4B 1,368B | Capitalization | 15.83B 1,322B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 128B | Net income 2025 * | 1.44B 120B | EV / Sales 2024 * | 1.93 x |
Net Debt 2024 * | 14.82B 1,237B | Net Debt 2025 * | 12.25B 1,022B | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
11.2
x | P/E ratio 2025 * |
10.5
x | Employees | 35,737 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
1 day | +1.45% | ||
1 week | -0.74% | ||
Current month | -1.85% | ||
1 month | -3.02% | ||
3 months | +12.50% | ||
6 months | +52.09% | ||
Current year | +32.49% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/23/01 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/19/22 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/15/01 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/20/09 |
Sol Barer
CHM | Chairman | 76 | 01/15/01 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 14.05 | -0.08% | 7,592 |
02/24/02 | 14.06 | +1.29% | 608,816 |
01/24/01 | 13.88 | -1.45% | 12,887 |
30/24/30 | 14.08 | -0.81% | 13,718 |
29/24/29 | 14.2 | +1.95% | 11,135 |
Delayed Quote London S.E., May 03, 2024 at 09:00 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.44% | 662B | |
+21.96% | 546B | |
-5.29% | 359B | |
+16.90% | 323B | |
+4.79% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.97% | 167B |
- Stock Market
- Equities
- TEVA Stock
- 0LER Stock